The most broadly successful treatment for human disease is provided by our own immune system. This includes all infections, growth of abnormal tissues, and autoimmune diseases. An intact and functioning immune system maintains a disease free state while suppressed or dysfunctional immune system leaves us susceptible to a wide range of maladies almost without restriction.
Common denominators created by the immune system are sought for the treatment to disease rather than diverse chemical substances unrelated to human evolution. After fourteen years of research, BioChem Solutions is honored to announce the development of an extraordinary breakthrough medicinal agent.
This patented agent is a 1,2,4 -Trioxolane designated as "Alphamir." Alphamir is a high- energy bio-oxidant that mimics and augments the natural production of bio-oxidants by the human immune system and white blood cells.
Alphamir is non-toxic and microorganisms cannot develop resistance. It is effective in a broad spectrum of applications including autoimmune disease, arthritis, viral disease, infections, burns and many dermatological conditions. Alphamir requires no monitoring or training for its distribution and will be available for a small fraction of the cost of present treatments.
Multiple clinical trials have been completed and Alphamir has been registered and approved for sale by the Ministry of Health of Kenya (FDA) Africa for use in HIV/AIDS and Arthritis. This approval, May 24, 2001, is valid in twenty eight African Countries.
Protocols are now ready to begin trials at the Kenya Medical Research Institute for our contraceptive vaginal gel, Prophamir, which will prevent the transmission of AIDS.
See our business plan for other diseases tested. We are prepared to initiate wide scale treatments in Africa immediately upon funding.